Kosaka 2017.

Trial name or title	Assessment of efficacy of a CKD support decision making application and home blood pressure measurement system in patients with CKD: study protocol of a randomized, controlled trial
Methods	Clinical, prospective, RCT with balanced randomisation (1:1)
Participants	Inclusion criteria: patient at the kidney internal medicine outpatient clinics, age over 20 years old, provision of informed consent, to be assure by doctor, RRT not yet selected, and eGFR < 60
Interventions	Intervention: will receive conventional care from the attending physician; the patient and physician will also be given a tablet equipped with the CKD‐SDM app and an automated sphygmomanometer for home blood pressure monitoring for 2 months. The CKD‐SDM app includes 61 items in three categories: "Let’s study CKD", "What’s about RRT?", and “Learn and consent of CKD”. Control: will receive conventional care and only the automated sphygmomanometer for 2 months
Outcomes	The primary outcome measure is change in home BP data from baseline. Secondary outcomes are renal function, spot urine test, self‐efficacy for chronic illness, disease burden, knowledge level of self‐management in CKD, and decision for RRT
Starting date	Recruitment began in March 2017
Contact information	Shiho Kosaka skosaka‐tky@umin.ac.jp
Notes	UMIN clinical trials last updated on 25/07/2017